Je was op zoek naar: tih (Deens - Engels)

(tih)
treatment of tumour-induced hypercalcaemia (tih) .

nyreinsufficiens tih:
renal impairment tih:

behandling af tih
treatment of tih

enhver sre (+tih)
any sre (+tih)

enhver sre (+tih) zometa
any sre (+tih)

behandling af tih voksne og ældre
treatment of tih adults and elderly

- behandling af tumorinduceret hypercalcæmi (tih).
- treatment of tumour-induced hypercalcaemia (tih).

resultater fra kliniske studier vedrørende behandling af tih
clinical trial results in the treatment of tih

behandling af voksne patienter med hypercalcæmi (tih).
treatment of adult patients with tumour-induced hypercalcaemia (tih).

behandling af voksne patienter med tumorinduceret hypercalcæmi (tih).
treatment of adult patients with tumour-induced hypercalcaemia (tih).

andel af patienter med fuldt respons pr. dag i de kombinerede tih- studier
proportion of complete responders by day in the combined tih studies

for at vurdere virkningerne af zometa i forhold til 90 mg pamidronat blev resultaterne af to pivotale multicenterundersøgelser af patienter med tih kombineret i en forud planlagt analyse.
to assess the effects of zometa versus pamidronate 90 mg, the results of two pivotal multicentre studies in patients with tih were combined in a pre-planned analysis.

patienter med tih og verificeret forværret nyrefunktion bør evalueres på relevant vis, og det bør overvejes om den potentielle gavn af behandling med zoledronsyre actavis opvejer de mulige ricisi.
patients with tih and evidence of deterioration in renal function should be appropriately evaluated with consideration given as to whether the potential benefit of treatment with zoledronic acid actavis outweighs the possible risk.

patienter med tih med verificeret forværret nyrefunktion bør evalueres på relevant vis, og det bør overvejes, om den potentielle gavn af behandling med zoledronsyre opvejer de mulige ricisi.
patients with tih with evidence of deterioration in renal function should be appropriately evaluated with consideration given as to whether the potential benefit of treatment with zoledronic acid outweighs the possible risk.

behandling med zometa til tih-patienter, som også har svær nyreinsufficiens, bør kun overvejes efter vurdering af risici og fordele ved behandlingen.
zometa treatment in tih patients who also have severe renal impairment should be considered only after evaluating the risks and benefits of treatment.

resultater fra kliniske undersøgelser vedrørende behandling af tih kliniske studier af tumorinduceret hypercalcæmi (tih) viser, at effekten af zoledronsyre er karakteriseret ved fald i serumcalcium og urinudskillelse af calcium.
clinical trial results in the treatment of tih clinical studies in tumour-induced hypercalcaemia (tih) demonstrated that the effect of zoledronic acid is characterised by decreases in serum calcium and urinary calcium excretion.